US Stem Cell Inc (USRM)

[Lonewolf1]

Five years is a very long time in the current landscape of advances in medical technology.

With any degree of success we could easily be at $5-6 IMHO.

The catalyst will be continued revenue and earnings growth as well as establishing a good relationship with the FDA. As soon as RMAT guidelines are published and clear they will likely make public their plans in relation to these guidelines. When this happens, The price could easily make a move back to the more recent highs around $.17. This is a point of resistance which when broken will signal higher, perhaps much higher prices. The average daily trading volume will return to the former levels and all this comical nonsense we have seen in the last month will suddenly cease - like magic. Many naysayers will also suddenly “go on sabbatical “. :)

This is all IMHO, but it seems fairly obvious, especially with the price as low as it is now.

GLTA

Tick tock....tick tock....